An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
IDG Capital
Activity from announced rounds
IDG Capital is the investment firm identified in InfiMaker records and as an angel-round co-lead by Apex Intelligence.
Recorded funding activity
Apex develops models for generating and testing scientific hypotheses. InfiMaker builds desktop five-axis CNC machines, while Anew develops AI-assisted medicines. The investor identity remains separate from former India-focused IDG Ventures and named funds.
- Rounds participated in
- 7
- Confirmed lead rounds
- 2 4 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $510M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
7 in this selectionApex Intelligence is developing self-evolving foundation models to help researchers generate and test scientific hypotheses.
Makes desktop five-axis CNC machines for engineers and small businesses
AI platform generating 3D models and personalized physical products
Building agentic AI systems for capital markets
Builds humanoid robots with fully in-house hardware for logistics and industrial deployment at scale
Today AI develops a personal assistant that uses memory and context to help users organise information and complete tasks.